AsiaIPEX is a one-stop-shop for players in the IP industry, facilitating IP trade and connection to the IP world. Whether you are a patent owner interested in selling your IP, or a manufacturer looking to buy technologies to upgrade your operation, you will find the portal a useful resource.
MODIFIED IMMUNOGENIC PEPTIDE AGAINST STREPTOCOCCUS A
Summary
An immunogenic peptide for prevention and treatment of group A streptococcus streptococcus-associated diseases and conditions
Technology Benefits
Vaccine to prevent group A streptococci infection
Technology Application
Vaccine - disease prevention
Detailed Technology Description
The present inventors have discovered that the immunogenicity of a p145 peptide can be substantially increased by targeted modification of the amino acid sequence of p145. A single immunization with the modified p145 peptide, rather than multiple immunizations, can protect against group A streptococcus infection even by hypervirulent strains such as the CovR/S mutant strain.
Type of Cooperation
Licensing
Application Date
23/08/2017 00:00:00
Application No.
2019439
Country/Region
Netherlands
For more information, please click Here
